Id |
Subject |
Object |
Predicate |
Lexical cue |
T51 |
0-2 |
Sentence |
denotes |
3. |
T52 |
3-63 |
Sentence |
denotes |
Potential Targets for Drug Development against Coronaviruses |
T53 |
64-195 |
Sentence |
denotes |
It has been shown at the time of writing that ACE-2 receptors in the lungs are specific targets for SARS-CoV-2 spike proteins [15]. |
T54 |
196-423 |
Sentence |
denotes |
It has been found that lung parenchyma must be in the differentiated state of the cell cycle and must express the ACE-2 receptor on the apical side, i.e., the site of the first contact with air, of the parenchyma [16,17,18,19]. |
T55 |
424-543 |
Sentence |
denotes |
It is no surprise therefore that the SARS, MERS, and SARS-CoV-2 viruses cause significant lung injury [20,21,22,23,24]. |
T56 |
544-755 |
Sentence |
denotes |
ACE-2 is also expressed to a significant extent in the gastrointestinal tract (GIT) [25] which accounts for the GIT symptoms that appeared in SARS-CoV patients and currently in SARS-CoV-2 infected patients [26]. |
T57 |
756-921 |
Sentence |
denotes |
Current pharmaceutical efforts against coronaviruses aim to interfere with the binding of the viral glycans in their spike proteins to potential host cell receptors. |
T58 |
922-1079 |
Sentence |
denotes |
The drug umifenovir has been shown to prevent the fusion of viral S-proteins with the host cell ACE-2 receptors, therefore excluding cell entry of the virus. |
T59 |
1080-1172 |
Sentence |
denotes |
However, umifenovir was clinically inefficient to improve the Covid-19 disease outcome [27]. |
T60 |
1173-1298 |
Sentence |
denotes |
A contributing membrane-bound enzyme that facilitates spike protein entry via ACE-2 receptors is the TMPRSS2 serine protease. |
T61 |
1299-1479 |
Sentence |
denotes |
This protease primes the coronavirus spike protein for entry by cleaving protein domains that increase the interaction with host cell membranes that result in membrane fusion [28]. |
T62 |
1480-1621 |
Sentence |
denotes |
It was also suggested that TMPRSS2 cleaves ACE-2 sites that promote the affinity for the viral spike protein, hence enhances cell entry [29]. |
T63 |
1622-1776 |
Sentence |
denotes |
Another possible target for treatment is the inhibition of the synthesis of the required saccharides that are incorporated in the host cell glycoproteins. |
T64 |
1777-1920 |
Sentence |
denotes |
Several quinine derivatives showed that these saccharide moieties known as sialic acids could be inhibited by drugs such as hydroxychloroquine. |
T65 |
1921-2072 |
Sentence |
denotes |
The quinines, therefore, decrease the number of glycan targets that could be engaged by coronaviral spike proteins to facilitate cell entry [30,31,32]. |
T66 |
2073-2200 |
Sentence |
denotes |
However, quinine derivatives pose significant cardiotoxicity that precludes their application as a treatment for Covid-19 [33]. |
T67 |
2201-2336 |
Sentence |
denotes |
Antiretrovirals such as nelfinavir have proven to be efficient inhibitors of post-entry replication of the virions of SARS-CoV [34,35]. |
T68 |
2337-2545 |
Sentence |
denotes |
It has been found that protease inhibitors used in SARS and MERS studies prevented the cleavage and activation of spike proteins following the translation of precursor polypeptides from the viral RNA [36,37]. |
T69 |
2546-2643 |
Sentence |
denotes |
RNA is a vital step towards the ultimate formation of the structural protein of new viruses [34]. |
T70 |
2644-2794 |
Sentence |
denotes |
Ritonavir and lopinavir [38] have shown some good activity against the SARS-CoV protein cleavage that ultimately prevents spike proteins from forming. |
T71 |
2795-2952 |
Sentence |
denotes |
Some investigated drugs have been reviewed as protease inhibitors against coronaviruses and the reader is referred to the publication by Adedeji et al. [39]. |
T72 |
2953-3034 |
Sentence |
denotes |
Figure 2 shows the currently identified targets for which drugs are investigated. |
T73 |
3035-3134 |
Sentence |
denotes |
Vaccination efforts are attempting to create a substrate that can be recognized by dendritic cells. |
T74 |
3135-3249 |
Sentence |
denotes |
The dendritic cells will subsequently label the virus spike proteins with coronavirus specific CD4+/CD8+ peptides. |
T75 |
3250-3371 |
Sentence |
denotes |
These specifically loaded particles will then be presented to T-cells that interact with T-lymphocyte dependent antigens. |
T76 |
3372-3564 |
Sentence |
denotes |
This interaction results in the induction of B-lymphocytes that produces antibodies that can recognize the spike proteins of coronaviruses to afford phagocytosis and destructions of the virus. |
T77 |
3565-3762 |
Sentence |
denotes |
It is also expected that memory T-cells will form which could result in long-term immunity when these cells are replicated when a spike protein can be recognized by dendritic or other immune cells. |
T78 |
3763-3901 |
Sentence |
denotes |
The carbohydrate-based vaccine holds promise to present recognizable glycan arrays that are representative of the targeted pathogens [41]. |
T79 |
3902-4115 |
Sentence |
denotes |
Very recently, several targets have been identified for the development of SARS-CoV-2 vaccines that have been identified based on the similarity of the virus to a previously encountered coronavirus, SARS-CoV [42]. |
T80 |
4116-4368 |
Sentence |
denotes |
It has been proven that many of the human pathogenic coronaviruses share a significant genomic overlap of more than 99.9% and this provides the basis for developing vaccines from a previously encountered coronavirus infection before SARS-CoV-2 [15,43]. |
T81 |
4369-4534 |
Sentence |
denotes |
The Middle East respiratory syndrome-related coronavirus, MERS-CoV, and SARS-CoV form part of these β-coronaviruses which wreaked havoc in the last two decades [44]. |
T82 |
4535-4692 |
Sentence |
denotes |
Therefore, one of the most promising targets is the characterization of spike protein epitopes that can be recognized by immune cells such as B- and T-cells. |
T83 |
4693-4934 |
Sentence |
denotes |
Some form of replication of this spike protein epitope should, therefore, be developed and this will hopefully provide the antigens which can bind to, for example, B- or T-cell antibodies and alert the immune system to coronaviruses [44,45]. |
T84 |
4935-5082 |
Sentence |
denotes |
A recombinant vaccination approach could be demonstrated by expressing the receptor-binding domain [46] of SARS-CoV spike protein in an adenovirus. |
T85 |
5083-5241 |
Sentence |
denotes |
This recombinant adenovirus was administered nasally and T-cells showed a significant immune response towards the expressed spike protein-binding domain [47]. |
T86 |
5242-5391 |
Sentence |
denotes |
Recombinant DNA approaches have made significant strides towards the synthesis of peptide sequences that can directly bind to spike protein epitopes. |
T87 |
5392-5460 |
Sentence |
denotes |
Spike proteins of the MERS-CoV were neutralized in this way [48,49]. |
T88 |
5461-5580 |
Sentence |
denotes |
The spike protein antigen of the MERS-CoV was also reported and identified targets for spike protein deactivation [50]. |
T89 |
5581-5718 |
Sentence |
denotes |
It is emphasized that the discussion of chemotherapeutic and vaccination efforts is superficial and not covered in detail in this report. |
T90 |
5719-5829 |
Sentence |
denotes |
Of importance though is the fact that antigen-antibody interactions are a key interest in developing vaccines. |
T91 |
5830-5980 |
Sentence |
denotes |
This recognition mechanism is creating the prelude for the discussion of the layer-by-layer nanocoating process that will be elaborated in due course. |